Accelerate your NASH drug discovery and development programs with our NASH model.
We use our unique human hepatocyte model to design and implement in vitro studies to generate data that our clients have used to inform their NASH drug discovery and development strategies. Our collaborations have helped our clients develop and commercialize drugs indicated for liver disease, including projects to:
- Evaluate and select leads
- Address regulatory questions
- Estimate initial dose range for first time in humans (FTIH) studies